2020 Annual Meeting | C22 - Actualización en desordenes cognitivos y epilepsia (Update in Cognitive Disorders and Epilepsy)
| 09:30 AM - 10:30 AM | Speaker |
Biological Markers of Alzheimer's Dementia
|
| 09:45 AM - 10:30 AM | Discussion |
Clinical and Therapeutic Implications of Biological Markers of Alzheimer's Disease
Christian J. Camargo, MD |
| 10:30 AM - 11:30 AM | Speaker |
Treatment-resistant Focal Epilepsy
|
| Andres M. Kanner, MD, FAAN | Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai. |
| David King-Stephens, MD | Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. King-Stephens has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. |
| Christian J. Camargo, MD | Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Camargo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GE Health. The institution of Dr. Camargo has received research support from 好色先生. |